These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma. Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of serum copper, zinc and plasma fibrinogen in cirrhotic patients with and without hepatocellular carcinoma. Doğan UB; Cindoruk M; Dumlu S; Unlü R; Unal S Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):476-7. PubMed ID: 9494860 [No Abstract] [Full Text] [Related]
11. Clinicopathological aspects of primary hepatocellular carcinoma occurring in patients with liver cirrhosis. Iwamura K Tokai J Exp Clin Med; 1982 Sep; 7(5):589-605. PubMed ID: 6190271 [TBL] [Abstract][Full Text] [Related]
12. Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma. Cheng BQ; Jia CQ; Liu CT; Lu XF; Zhong N; Zhang ZL; Fan W; Li YQ Dig Liver Dis; 2008 Jun; 40(6):446-52. PubMed ID: 18294942 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of serum cytokeratin-19 fragment (CYFRA 21-1) in hepatocellular carcinoma. Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Ono K; Kubo S J Hepatobiliary Pancreat Surg; 2006; 13(3):239-44. PubMed ID: 16708302 [TBL] [Abstract][Full Text] [Related]
14. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma? Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105 [TBL] [Abstract][Full Text] [Related]
15. Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B. Wong CB; Attar BM; Shimoda SS Am J Gastroenterol; 1995 Jun; 90(6):1015-6. PubMed ID: 7539578 [No Abstract] [Full Text] [Related]
16. Some haematological observations of Kenyan hepatocellular carcinoma (HCC) patients. Mukiibi JM; Mwaungulu GS; Wankya BM East Afr Med J; 1982 Feb; 59(2):118-26. PubMed ID: 6290180 [No Abstract] [Full Text] [Related]
17. Vascular endothelial growth factor receptor-1 levels in hepatocellular carcinoma and correlations with clinicopathological features. Yolcu OF; Köklü S; Yüksel O; Coban S; Ayaz S; Akif Oztürk M; Benekli M Hepatogastroenterology; 2007; 54(77):1526-8. PubMed ID: 17708290 [TBL] [Abstract][Full Text] [Related]
18. [The problem of immunochemical diagnosis of primary cancer of the liver]. Assekrutova IV; Abelev GI; Kraevskiĭ NA; Perova SD; Perevodchikova NI Vestn Akad Med Nauk SSSR; 1967; 22(5):75-81. PubMed ID: 4174294 [No Abstract] [Full Text] [Related]
19. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients. Alisa A; Ives A; Pathan AA; Navarrete CV; Williams R; Bertoletti A; Behboudi S Clin Cancer Res; 2005 Sep; 11(18):6686-94. PubMed ID: 16166448 [TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein and hepatocellular carcinoma. Colli A; Fraquelli M; Conte D Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257 [No Abstract] [Full Text] [Related] [Next] [New Search]